MarketScan by Merative

As 2024 comes to an end, our Truven by Merative team has so much to be proud of. This year, we introduced new specialty datasets to strengthen our MarketScan databases and get us one step closer to uncovering the complete picture of patient health. In 2025, we have even more new data on the horizon. Read about our accomplishments and get a sneak peek for what we have planned: https://lnkd.in/e2cYVrEe

To effectively leverage real-world data, you must align your data sources with your trial design and research questions. Finding the right data begins with asking the right questions. Here are 5 questions to consider: https://lnkd.in/dKyrQwmu

Last week, we spoke with experts from the CDC and Dana-Farber Cancer Institute on how #MortalityData is driving health research forward. The insights they shared were nothing short of inspiring. One powerful example: Mortality data helped identify key policy barriers for #BloodCancer patients and advocate for improved access to high-quality end-of-life care. Want to learn more? Watch the 30-minute replay for more examples on how mortality data helps evaluate end-of-life care, inform health policy decisions, and assess gaps and biases in healthcare: https://lnkd.in/eVTMF4Db

⏰ Last chance to register! ⏰ Join our fireside chat TOMORROW with experts from the Centers for Disease Control and Prevention and Dana-Farber Cancer Institute. Gain insights into the value of mortality data, the challenges researchers face, and how mortality data is strengthening their research: https://lnkd.in/dJifn9jN

As competition increases, healthcare organizations face pressure to negotiate optimal contracted rates. Our client, a leading healthcare consulting firm, used MarketScan Reimbursement Benchmarks to help a health system optimize their reimbursement rates. As a result, the health system built a payer negotiation strategy, resulting in an average increase of 6–12% in professional contracted rates from their commercial plans. Read the case study: https://lnkd.in/et-5b8cz

Mortality is one of the most objectively measurable endpoints in health outcomes research, yet finding quality, research-grade mortality data can be a challenge. These insights are critical for understanding treatment effectiveness, population health trends, and informing future research directions. Don't miss this fireside chat, where experts from the Centers for Disease Control and Prevention and Dana-Farber Cancer Institute will discuss the transformative potential of mortality data in research, the challenges they face, and how they’re applying it to their work. Register now: https://lnkd.in/dJifn9jN

We’re excited to host a fireside chat with leading experts from the Centers for Disease Control and Prevention and Dana-Farber Cancer Institute. The conversation will focus on the transformative potential of mortality data in research and how they’re applying it to their work. Register now: https://lnkd.in/dJifn9jN

What are you doing on October 16th at 11am ET? Tune in to hear Liisa Palmer share insights on a podcast series, Real World Wednesday, to discuss important considerations around “fit-for-purpose” data in a rapidly expanding ecosystem. Join the conversation:  https://lnkd.in/eraGiDzm

October is National #Depression and #MentalHealth Screening Month, shining a light on the everyday battle faced by millions of Americans. To better treat and prevent mental health disorders, we first need to understand them. Check out our report, powered by MarketScan data, for an in-depth look at the state of depression in the United States: https://lnkd.in/ej4p73x5

Today is a huge milestone for healthcare research with the new Linked Claims + EHR Database by MarketScan and Veradigm® becoming officially available! Read the announcement: https://lnkd.in/eWRJmRhu This database provides an accurate, comprehensive view into patient journeys, healthcare utilization, and costs – while maintaining scientific and methodological rigor.